Mst Safety Questions, Mst Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about Mst side effects. Our extensive database of Mst adverse events and Mst warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Doctors about Mst
Mst Safety Reports
Total Mst reports: 18.Mst FDA safety alerts: 2002 2006 2007 .
Reported deaths: 6 Reported hospitalizations: 7.
Take Mst Side Effects Survey or Share Your Mst Story.
Reported Mst Side Effects: weight increased, pneumonia, emphysema, bronchospasm, bronchitis, syncope, munchausen's syndrome, cough, feeling abnormal, dyspnoea, accidental overdose.
Read More Here.
Consumer or non-health professional from reported MST problem on Jan 19, 2007. Female patient, 70 years of age, was diagnosed with back pain, vomiting, atrial fibrillation and was treated with MST. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, nausea, respiratory disorder, snoring, somnolence, vomiting. MST dosage: 60 MG, BID. During the same period patient was treated with SEVREDOL, PRIMPERAN, APOCARD, CLEXANE, CARVEDILOL, ACTONEL, OMEPRAZOLE, NATECAL D. Patient died on 12/06/2006.
MST problem was reported by a Consumer or non-health professional from on Jan 29, 2007. Female patient, 61 years of age, weighting 154.3 lb, was diagnosed with pain, depression and was treated with MST. After drug was administered, patient experienced the following problems/side effects: myalgia, restlessness, transaminases increased. MST dosage: unknown. During the same period patient was treated with SERTRALINE, OXAZEPAM, URSODIOL, PANTOZOL, THYRAX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported MST problem on Feb 02, 2007. Male patient, 71 years of age, was diagnosed with cancer pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: accidental overdose. MST dosage: 200 MG, SINGLE. Patient died on 06/25/2006.
MST problem was reported by a Consumer or non-health professional from on Feb 14, 2007. Male patient, 71 years of age, was diagnosed with cancer pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: accidental overdose. MST dosage: 200 MG, SINGLE. Patient died on 06/25/2006.
Consumer or non-health professional from reported MST problem on Feb 15, 2007. Female patient, 70 years of age, was diagnosed with osteoarthritis and was treated with MST. After drug was administered, patient experienced the following problems/side effects: cardiac failure, incorrect dose administered. MST dosage: 20 MG, BID. Patient died.
MST problem was reported by a Consumer or non-health professional from on Feb 22, 2007. Female patient, 82 years of age, was diagnosed with cancer pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, respiratory depression, respiratory failure. MST dosage: 60 MG, Q12H. During the same period patient was treated with PERINDOPRIL ERBUMINE, ISOSORBIDE MONONITRATE, INSULIN. Patient was hospitalized. Patient died on 02/18/2007.
Consumer or non-health professional from reported MST problem on June 14, 2007. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with neuralgia and was treated with MST. After drug was administered, patient experienced the following problems/side effects: confusional state, electrocardiogram abnormal, hypokalaemia, metabolic alkalosis. MST dosage: 60 MG, TID. Patient was hospitalized. Patient recovered.
MST problem was reported by a Consumer or non-health professional from on Mar 07, 2005. Male patient, 45 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: bronchitis, bronchospasm, dyspnoea, emphysema, pneumonia, weight increased. MST dosage: 100 MG, QID. During the same period patient was treated with SEVREDOL, VIANI. Patient recovered.
Consumer or non-health professional from reported MST problem on Mar 07, 2005. Male patient, 45 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: bronchitis, bronchospasm, dyspnoea, emphysema, pneumonia, weight increased. MST dosage: 100 MG, QID. During the same period patient was treated with SEVREDOL, VIANI. Patient recovered.
MST problem was reported by a Physician from GERMANY on Aug 30, 2006. Male patient, 45 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: bronchitis, bronchospasm, emphysema, pneumonia, weight increased. MST dosage: 100 MG, QD, ORAL. During the same period patient was treated with SEVREDOL, VIANI. Patient recovered.
Consumer or non-health professional from reported MST problem on Sept 22, 2006. Female patient was treated with MST. After drug was administered, patient experienced the following problems/side effects: accidental exposure, consciousness fluctuating. MST dosage: 150 MG, UNK. Patient was hospitalized. Patient recovered.
MST problem was reported by a Consumer or non-health professional from on Oct 06, 2006. Male patient was diagnosed with bone pain, back pain, muscle spasms and was treated with MST. After drug was administered, patient experienced the following problems/side effects: anorexia, bedridden, insomnia, thirst decreased. MST dosage: unknown. During the same period patient was treated with DICONAL, DIHYDROCODEINE BITARTRATE, DIAZEPAM. Patient recovered.
Consumer or non-health professional from reported MST problem on Nov 22, 2006. Male patient, 50 years of age, was diagnosed with pain, constipation and was treated with MST. After drug was administered, patient experienced the following problems/side effects: anorgasmia, ejaculation failure, feeling abnormal. MST dosage: 30 MG, DAILY. During the same period patient was treated with CYMBALTA, ACETAMINOPHEN W, MOVICOL. Patient recovered.
MST problem was reported by a Consumer or non-health professional from on Aug 23, 2006. Female patient, 80 years of age, was diagnosed with back pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. MST dosage: 10 MG, TID. During the same period patient was treated with BENZODIAZEPINE DERIVATIVES. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported MST problem on June 29, 2007. Male patient, 29 years of age, was diagnosed with myalgia and was treated with MST. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, gynaecomastia, myalgia. MST dosage: unknown. Patient recovered.
MST problem was reported by a Consumer or non-health professional from on Sept 07, 2007. Female patient, 37 years of age, was diagnosed with pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, cough, headache, munchausen's syndrome, syncope. MST dosage: 30 MG, BID. During the same period patient was treated with SKENAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported MST problem on Sept 07, 2007. Female patient, 37 years of age, was diagnosed with pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: cough, munchausen's syndrome, syncope. MST dosage: 30 MG, BID. During the same period patient was treated with VIGIL. Patient was hospitalized. Patient recovered.
MST problem was reported by a Consumer or non-health professional from on Sept 10, 2007. Male patient, 76 years of age, was diagnosed with cancer pain and was treated with MST. After drug was administered, patient experienced the following problems/side effects: brain oedema, completed suicide, intentional overdose, pulmonary oedema, respiratory arrest. MST dosage: 30 MG, TID. During the same period patient was treated with ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE AGENTS, IBUPROFEN, TRAMADOLOR. Patient died.